Literature DB >> 34344305

Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report.

Samuel D Racette1, Borislav A Alexiev2, Michael P Angarone3, Ajay Bhasin4,5, Kaitlin Lima6, Lawrence J Jennings2, Senthil Balasubramanian7, Akihiro J Matsuoka8,9,10.   

Abstract

BACKGROUND: We present a yet to be described association of SARS-CoV-2 infection with Kikuchi-Fujimoto disease. CASE
PRESENTATION: A 32-year-old physician with history of SARS-CoV-2 infection presented to the emergency department with 2 weeks of fever, chills, and right sided cervical lymphadenopathy. He was treated empirically for presumed folliculitis with worsening of symptoms leading to repeat presentation to the emergency department. Extensive workup was unrevealing of an infectious cause and needle biopsy of the lesion was unrevealing. An excisional lymph node biopsy revealed follicular hyperplasia with necrotic foci showing abundance of histiocytes at the edge of necrosis with CD8 predominance of T-cells. Final diagnosis was deemed to be Kikuchi-Fujimoto disease. Antibiotic therapy was discontinued, and the patient's symptoms resolved with steroid therapy and expectant management.
CONCLUSIONS: This is the first report of a patient developing Kikuchi-Fujimoto disease following SARS-CoV-2 infection. Clinicians should be aware of Kikuchi-Fujimoto disease as a possibility when approaching patients with hyper-inflammatory states who present with cervical lymphadenopathy.
© 2021. The Author(s).

Entities:  

Keywords:  COVID-19; Cervical lymphadenopathy; Kikuchi-Fujimoto Syndrome; SARS-CoV-2

Year:  2021        PMID: 34344305     DOI: 10.1186/s12879-021-06048-0

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  3 in total

Review 1.  Kikuchi-Fujimoto Disease: A Review.

Authors:  Anamarija M Perry; Sarah M Choi
Journal:  Arch Pathol Lab Med       Date:  2018-11       Impact factor: 5.534

Review 2.  Enigmatic Kikuchi-Fujimoto disease: a comprehensive review.

Authors:  Xavier Bosch; Antonio Guilabert; Rosa Miquel; Elias Campo
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

3.  Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

Authors:  Yanchun Peng; Alexander J Mentzer; Guihai Liu; Xuan Yao; Zixi Yin; Danning Dong; Wanwisa Dejnirattisai; Timothy Rostron; Piyada Supasa; Chang Liu; César López-Camacho; Jose Slon-Campos; Yuguang Zhao; David I Stuart; Guido C Paesen; Jonathan M Grimes; Alfred A Antson; Oliver W Bayfield; Dorothy E D P Hawkins; De-Sheng Ker; Beibei Wang; Lance Turtle; Krishanthi Subramaniam; Paul Thomson; Ping Zhang; Christina Dold; Jeremy Ratcliff; Peter Simmonds; Thushan de Silva; Paul Sopp; Dannielle Wellington; Ushani Rajapaksa; Yi-Ling Chen; Mariolina Salio; Giorgio Napolitani; Wayne Paes; Persephone Borrow; Benedikt M Kessler; Jeremy W Fry; Nikolai F Schwabe; Malcolm G Semple; J Kenneth Baillie; Shona C Moore; Peter J M Openshaw; M Azim Ansari; Susanna Dunachie; Eleanor Barnes; John Frater; Georgina Kerr; Philip Goulder; Teresa Lockett; Robert Levin; Yonghong Zhang; Ronghua Jing; Ling-Pei Ho; Richard J Cornall; Christopher P Conlon; Paul Klenerman; Gavin R Screaton; Juthathip Mongkolsapaya; Andrew McMichael; Julian C Knight; Graham Ogg; Tao Dong
Journal:  Nat Immunol       Date:  2020-09-04       Impact factor: 25.606

  3 in total
  4 in total

1.  Kikuchi-Fujimoto Disease Following COVID-19.

Authors:  Hussain A Al Ghadeer; Sajjad M AlKadhem; Mohammed S AlMajed; Hassan M AlAmer; Jaber A AlHabeeb; Suad H Alomran; Abdullah S AlMajed
Journal:  Cureus       Date:  2022-01-09

2.  Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.

Authors:  Takeru Kashiwada; Yoshinobu Saito; Yasuhiro Terasaki; Yukari Shirakura; Kaoruko Shinbu; Toru Tanaka; Yosuke Tanaka; Masahiro Seike; Akihiko Gemma
Journal:  Hum Vaccin Immunother       Date:  2022-05-18       Impact factor: 4.526

3.  Multisystem Inflammatory Syndrome in Adults Accompanied with Kikuchi-Fujimoto Disease.

Authors:  Eriko Kashihara; Kosuke Doi; Kohei Fujita
Journal:  Intern Med       Date:  2022-06-14       Impact factor: 1.282

4.  Kikuchi-Fujimoto Disease Following COVID-19 Infection in a 7-Year-Old Girl: A Case Report and Literature Review.

Authors:  Yusuke Saito; Yuta Suwa; Yakuto Kaneko; Mitsuhiro Tsujiwaki; Yasuhisa Odagawa
Journal:  Cureus       Date:  2022-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.